GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Science/Technology SCI

Issues related to pharmaceutical innovation and intellectual property protection.

Contacted: Office of Management & Budget (OMB); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act

Contacted: Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Executive Office of the President (EOP); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Bills named: H.R. 9 (114th), S. 1137 (114th)

Foreign Relations FOR

Issues related to access to pharmaceuticals, international finance for health services and intellectual property protection.

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Office of Management & Budget (OMB); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE; Commerce, Dept of (DOC); State, Dept of (DOS)

Veterans VET

Appropriations; education related to Hepatitis C treatment guidelines and funding issues. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146.

Contacted: SENATE; Office of Management & Budget (OMB); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); Executive Office of the President (EOP); State, Dept of (DOS)

Bills named: H.R. 4810 (114th)

Defense DEF

Education related to HCV issues.

Contacted: Defense, Dept of (DOD); SENATE; Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); Executive Office of the President (EOP); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; HIV testing issues; ADAP issues; Hepatitis C issues; patent reform

Contacted: Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Defense, Dept of (DOD)

Health Issues HCR

Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program. S.1287 - Viral Hepatitis Testing Act of 2015.

Contacted: Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); SENATE; State, Dept of (DOS); Office of Management & Budget (OMB); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Bills named: S. 1287 (114th)

Medicare/Medicaid MMM

Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV testing, screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; Implementation of Public Law No: 111-148; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B.

Contacted: State, Dept of (DOS); Executive Office of the President (EOP); Commerce, Dept of (DOC); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE

Pharmacy PHA

Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; Issues related to coverage and reimbursement of pharmaceuticals; Issues related to Medicare, Medicaid and Affordable Care Act implementation; and FDA issues and 340B.

Contacted: Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); State, Dept of (DOS); Executive Office of the President (EOP)

Budget/Appropriations BUD

Issues related to healthcare funding and cost-savings.

Contacted: Executive Office of the President (EOP); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); SENATE; State, Dept of (DOS); Office of Management & Budget (OMB)